The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

E36: Baricitinib for SLE

April 4th, 2019

This week I discuss the phase 2 trial on baricitinib in SLE.  Though it's early times (and the total flop of rituxan in ME/CFS recently can attest to this), this was a large phase 2 and I'm hopeful it carries through to the ongoing phase 3 trials.  Follow me on twitter and find all the papers / links at my new landing page, ebrheum.com!

Podbean App

Play this podcast on Podbean App